Mendelian randomization in cardiometabolic disease: challenges in evaluating causality
Michael V. Holmes(University of Oxford), George Davey Smith(University of Bristol)
Cited by 743
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k
Meta‐analysis and<scp>Mendelian</scp>randomization: A review
|Research Synthesis Methods|2019|1.7k
Evaluating the potential role of pleiotropy in Mendelian randomization studies
|Human Molecular Genetics|2018|1.7k